Related Experiment Video
Updated: Jul 14, 2026
07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis.
Yong Hannah Wen1, Hartmut Koeppen, Roberto Garcia
1Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Human Pathology
|May 19, 2007
Summary
Epidermal growth factor receptor (EGFR) is expressed in over half of osteosarcoma cases and cell lines. Researchers identified two new EGFR gene alterations in tumor samples, warranting further investigation into their role in osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- ErbB receptor tyrosine kinases, including EGFR, are implicated in various cancers.
- Osteosarcoma research has primarily focused on HER-2, with conflicting results and limited evaluation of EGFR expression.
Purpose of the Study:
- To determine the expression level of EGFR in osteosarcoma.
- To analyze the mutational status of the EGFR gene in osteosarcoma samples and cell lines.
Main Methods:
- Immunohistochemistry was used to detect EGFR protein expression in 37 osteosarcoma tumor samples.
- EGFR expression was assessed in 12 established bone tumor-derived cell lines.
- Somatic alterations in the EGFR gene were identified using sequencing.
Main Results:
- EGFR protein expression was observed in 57% (21 of 37) of osteosarcoma cases, showing strong membranous staining.
- Moderate to high EGFR expression was found in 50% (6 of 12) of osteosarcoma cell lines.
- Two somatic alterations (E829E and R831C) were detected in the EGFR gene's cytoplasmic domain in one tumor sample.
Conclusions:
- EGFR is frequently expressed in osteosarcoma, suggesting a potential role in the cancer's development or progression.
- The identified EGFR alterations may have implications for osteosarcoma pathobiology.
- Further research is needed to elucidate the functional significance of EGFR expression and mutations in osteosarcoma.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...